Log In
BCIQ
Print this Print this
 

VAX161, VAX161C

  Manage Alerts
Collapse Summary General Information
Company VaxInnate Corp.
DescriptionRecombinant fusion protein that consists of the globular head domain of the hemagglutinin antigen (HA) of influenza A HA5 Indonesia fused to Salmonella typhimurium flagellin type 2 (STF2), a toll-like receptor 5 (TLR5) ligand
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against avian (H5N1) influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today